Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
Samuel R. Chamberlain, David S. Baldwin
CNS Drugs (2021) Vol. 35, Iss. 7, pp. 703-716
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders
Borwin Bandelow, Christer Allgulander, David S. Baldwin, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 2, pp. 79-117
Closed Access | Times Cited: 72
Screening for Neuroprotective and Rapid Antidepressant-like Effects of 20 Essential Oils
Khoa Nguyen Tran, Nhi Phuc Khanh Nguyen, Ly Thi Huong Nguyen, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1248-1248
Open Access | Times Cited: 28
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy
Mega O. Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
Vincent Van den Eynde, Wegdan R. Abdelmoemin, Magid M. Abraham, et al.
CNS Spectrums (2022) Vol. 28, Iss. 4, pp. 427-440
Open Access | Times Cited: 35
Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain
Elaine Meade, Sarah Hehir, Neil J. Rowan, et al.
Journal of Fungi (2022) Vol. 8, Iss. 3, pp. 290-290
Open Access | Times Cited: 19
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
EXPLORING NEW MONOAMINO OXIDASE- A (MAO-A) SELECTIVE INHIBITORS FROM CUCURBITO PEPO: A VIRTUAL SCREENING, MOLECULAR DOCKING, MD SIMULATIONS AND ADMET ANALYSIS
Mahendra Gowdru Srinivasa, Sudeep D. Ghate, R. Shyama Prasad Rao, et al.
International Journal of Applied Pharmaceutics (2025), pp. 293-303
Open Access
Seltorexant for major depressive disorder
Kyle Valentino, Kayla M. Teopiz, Sabrina Wong, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences
Pooja Singh, Boosani Vasundhara, Nabanita Das, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Update on neurobiological mechanisms of fear: illuminating the direction of mechanism exploration and treatment development of trauma and fear-related disorders
Ying Li, Weijia Zhi, Bing Qi, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Monoamine Oxidase Inhibitors for Trichotillomania
Jon E. Grant, Samuel R. Chamberlain
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 2, pp. 149-151
Open Access | Times Cited: 4
Effects of Antidepressants on Sleep in Post-traumatic Stress Disorder: An Overview of Reviews
Andreas S. Lappas, Zoi A. Polyzopoulou, George N. Christodoulou, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 749-805
Open Access | Times Cited: 4
Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements
Hesham A. Abou‐Zied, Eman A. M. Beshr, Alaa M. Hayallah, et al.
Journal of Molecular Structure (2023) Vol. 1296, pp. 136807-136807
Closed Access | Times Cited: 4
Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysis
Nilay Kumar Nandi, Shibam Das, Diksha Choudhary, et al.
Bioorganic Chemistry (2024), pp. 107148-107148
Closed Access | Times Cited: 1
Anxiety Disorders
David S. Baldwin, Bethan Impey, Vasilios G. Masdrakis
Cambridge University Press eBooks (2024), pp. 293-313
Closed Access | Times Cited: 1
Brain, Behavior, and Immunity Integrative Clinical Evidence & Advances in Traditional Chinese Medicine for Depression (TCM and Depression)｜Review
Yu Liu, Kaishun Bi, Sierra Hodges, et al.
Brain Behavior and Immunity Integrative (2024) Vol. 8, pp. 100094-100094
Open Access | Times Cited: 1
Exploring the national prevalence of mental health risk, multimorbidity and the associations thereof: a repeated cross-sectional panel study
Ashleigh Craig, Witness Mapanga, Asanda Mtintsilana, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Analysis of the Underlying Mechanism of the Jiu Wei Zhen Xin Formula for Treating Generalized Anxiety Disorder Based on Network Pharmacology of Traditional Chinese Medicine
Heng Shao, Quan Gan, Zhuangfei Chen, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 3
Antidepressant-Like Activity of Methanolic Extract From Old Areca Nut Using Forced Swim Test Method In Mice (Mus Musculus) Tested Independently
Riryn Novianty
JURNAL INOVASI PENDIDIKAN DAN SAINS (2024) Vol. 5, Iss. 1, pp. 31-40
Open Access
Construction of an antidepressant priority list based on functional, environmental, and health risks using an interpretable mixup-transformer deep learning model
Peixuan Sun, Huaishi Liu, Yuanyuan Zhao, et al.
Journal of Hazardous Materials (2024) Vol. 474, pp. 134651-134651
Closed Access
Nutritional Interventions vs. Pharmacological Interventions
Samar F. Darwish, Sherif S. Abdel Mageed, Ahmed Amr Raouf, et al.
(2024), pp. 445-465
Closed Access
Synthesis and evaluation of 2-methylbenzothiazole derivatives as monoamine oxidase inhibitors
Maryké Shaw, Jacobus P. Petzer, Theunis T. Cloete, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 10, pp. 1829-1837
Open Access
Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression
Amogh Patil, Summon Koul
Current Pharmaceutical Design (2024) Vol. 30, Iss. 33, pp. 2587-2596
Closed Access
Psychedelic research, assisted therapy and the role of the anaesthetist: A review and insights for experimental and clinical practices
Gisela Lima, Carla Soares, Marta Teixeira, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access
Page 1 - Next Page

Scroll to top